Nasdaq · Healthcare
SANUWAVE Health, Inc. (SNWV)
As-reported financials and recent SEC filings for SANUWAVE Health, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$44.1M
Net income
$11.8M
Net margin
26.8%
Diluted EPS
$0.41
ROE
729.6%
P/E (TTM)
—
Market cap
—
Debt / equity
10.0×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $44.1M | $32.6M | $20.4M | $16.7M | $13.0M |
| Gross profit | $34.0M | $24.6M | $14.4M | $12.4M | $8.0M |
| Operating income | $4.9M | $3.8M | $-540,000 | $-9.0M | $-14.1M |
| Net income | $11.8M | $-33.1M | $-25.8M | $-10.3M | $-27.3M |
| Diluted EPS | $0.41 | $-3.71 | $-3.05 | $-1.30 | $-3.25 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-07-02
View on EDGAR →42026-07-02
View on EDGAR →42026-07-02
View on EDGAR →42026-07-02
View on EDGAR →42026-07-02
View on EDGAR →8-K2026-06-16
View on EDGAR →8-K2026-06-15
View on EDGAR →SD2026-05-29
View on EDGAR →Largest Healthcare peers
Go deeper on SNWV
Search SANUWAVE Health, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.